The protein boom: Starbucks, Subway and beyond load up menus

Major restaurant chains are expanding high‑protein offerings to capture shifting consumer demand driven in part by GLP‑1 weight‑loss drugs and changing dietary preferences: Subway launched Protein Pockets (>20g protein, under $4), Starbucks rolled out Protein Cold Foam and protein lattes (≈15–36g protein per 16‑oz), Sweetgreen added a Protein Max Bowl (106g protein) and multiple 30g+ items, and Cava is adding premium proteins like roasted salmon. These product moves are positioned to lift average check and support menu modernization (notably part of Starbucks’ turnaround strategy) and reflect broader food‑tech innovations emphasizing nutrient density, but the announcements are incremental and likely to have limited near‑term market impact on equities.

Analysis

Market structure: Winners are branded premiumizers (SBUX, CAVA, Sweetgreen) and upstream protein suppliers (e.g., Tyson/TSN) that can monetize higher per-ticket spend; losers are discount/value-first chains and low-margin casual diners that cannot credibly premiumize. Expect a 1–3% uplift in AUVs for chains that convert menu mix to protein-heavy items within 3–12 months, and a 2–5% upward pressure on chicken/beef commodity prices over 6–12 months if rollout scales nationwide.

Risk assessment: Tail risks include a GLP‑1 regulatory backlash, major avian/animal disease disrupting supply (price spikes >20%), or consumer fatigue reversing the trend; these are low‑probability but high‑impact. Time buckets: immediate (weeks) — menu trials and social-media pickup; short (1–3 quarters) — comps and margin impact; long (2–4 years) — structural diet shift and supplier consolidation. Hidden dependencies: labor/time-of-service costs from more complex prep and supplier concentration risk for premium proteins.

Trade implications: Favor equities with pricing power and scale. Tactical plays: buy SBUX exposure via defined-cost call spreads to capture menu-driven upside; add selective long CAVA and small cap supplier exposure (TSN) for commodity upside. Pair trades: long premiumizer (SBUX) vs short margin‑vulnerable casual chains (e.g., EAT) to isolate mix benefit. Use options to size exposure and cap downside ahead of Q1–Q2 earnings that will reprice menu traction.

Contrarian angles: Consensus underestimates margin squeeze if protein input costs rise faster than guest willingness to pay — premiumization can boost revenue but compress or be margin neutral if protein costs +10–15%. Historical parallel: Atkins/low‑carb waves showed demand spikes can normalize in 12–36 months; service/time penalties and menu complexity are underappreciated risks that could erode the trade.

Key Decisions for Investors

• Establish a 1.5–2.5% long position in SBUX using a cost‑controlled options package: buy Jul 2026 95/105 call spread (or equivalent) within 2–6 weeks to capture menu rollout upside; take half profits at +20% and cut at -12%.
• Initiate a 0.5–1.5% long position in CAVA (CAVA) equity to play premiumization, target +25–35% over 6–12 months; use a 15% stop‑loss and increase to 2% if same‑store sales accelerate >3% on next quarter report.
• Add a 0.5–1% position in protein suppliers (e.g., TSN) as a hedge against commodity inflation; convert to a larger 2% position only if wholesale chicken/beef indices rise >5% month‑over‑month or USDA reports tightening supply.
• Implement a pair trade: long SBUX (as above) vs short Brinker (EAT) sized 1% net market exposure to capture relative pricing power; cover short if EAT outperforms by >8% on improving labor/productivity metrics within 2 quarters.
• Buy asymmetric optional upside on Sweetgreen (SG): purchase 12‑month Jan 2027 $8/$16 call spread (small notional) to play scaled nutrition transparency and product innovation; limit allocation to 0.5% and reassess after next two earnings releases.